NervGen Pharma Corp. NGEN
NASDAQ · United States · Health Technology
$1.81+0.05 (+2.84%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.27 | -0.06 | -338.1% | $0 | — | -1.4%$1.76→$1.74 |
| Q1 2026 | 2026-05-15 | -0.07 | -0.06 | -16.7% | — | — | -1.9%$3.71→$3.64 |
| Q4 2025 | 2026-03-31 | -0.27 | -0.07 | -285.7% | — | — | +16.9%$3.73→$4.36 |
| Q2 2025 | 2025-08-26 | -0.09 | -0.06 | -50.0% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.04 | -0.06 | +33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.